Skip to main content

SpyGlass Pharma, Inc.

corporate_fare Company Profile

SpyGlass Pharma, Inc.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed SGP - Latest Insights

SGP
Mar 26, 2026, 5:25 PM EDT
Source: Wiseek News
Importance Score:
7
SpyGlass Posts $39.9M Net Loss in 2025, Maintains Liquidity to Fund Operations Through 2028
Sentiment: Neutral
View Wiseek Article
SGP
Mar 26, 2026, 5:23 PM EDT
Filing Type: 10-K
Importance Score:
8
Annual Report Details Post-IPO Financials, Cash Runway, Material Weakness, and Glaukos Lawsuit
Sentiment: Neutral
View Wiseek Article
SGP
Mar 26, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
9
SpyGlass Pharma Reports Positive Phase 1/2 Data, Strong Cash Runway Post-IPO, and Advances Phase 3 Trials
Sentiment: Positive
View Wiseek Article
SGP
Mar 09, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
SpyGlass Pharma Reports Positive 12-Month Phase 1/2 Trial Results for BIM-IOL System, Advancing to Phase 3
Sentiment: Positive
View Wiseek Article
SGP
Mar 09, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
SpyGlass Pharma's BIM-IOL System Shows Strong 12-Month Phase 1/2 Results, Eliminating Topical Glaucoma Meds
Sentiment: Positive
View Wiseek Article
SGP
Feb 17, 2026, 7:21 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
9
RA Capital Management Discloses 24.1% Stake in SpyGlass Pharma Following IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 13, 2026, 6:21 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
8
New Enterprise Associates Discloses 22.2% Stake in SpyGlass Pharma Post-IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 13, 2026, 4:05 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
8
Gilde Healthcare Establishes 6.57% Stake in SpyGlass Pharma Post-IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 5:15 PM EST
Filing Type: 4
Importance Score:
9
RA Capital Management Increases SpyGlass Pharma Stake by $172M, Including $59M Open Market Buy
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
Director & 10% Owner Ali Behbahani Reports $184M Stock Acquisition, Including $15M Open Market Buy
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
8
10% Owner Florence Anthony A. Jr. Makes $15M Open Market Purchase Amidst Broader Insider Accumulation
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
10% Owner BASKETT FOREST Makes Substantial $184M Investment Post-IPO, Including $15M Open Market Purchase
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
10% Owner New Enterprise Associates Makes $15M Open Market Purchase Post-IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
10% Owner Yang Rick Makes $15M Open Market Purchase and Converts $133M Preferred Stock Post-IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
10% Owner Mohamad Makhzoumi Buys $15M in SpyGlass Pharma Stock Post-IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
10% Owner Sandell Scott D Makes $15M Open Market Purchase Post-IPO, Converts $169M Preferred Stock
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
8
10% Owner Carmen Chang Makes Substantial $15M Open Market Purchase Post-IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
10% Owner Edward Mathers Makes Substantial $15M Open Market Purchase Post-IPO
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
9
10% Owner Paul Edward Walker Makes Substantial $15M Open Market Purchase in SpyGlass Pharma
Sentiment: Positive
View Wiseek Article
SGP
Feb 11, 2026, 4:09 PM EST
Filing Type: 4
Importance Score:
8
Director Geoffrey Pardo Buys $5 Million in SpyGlass Pharma Stock Post-IPO
Sentiment: Positive
View Wiseek Article